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Letter to the Editor 
TELEMEDICINE DURING THE COVID-19 PANDEMIC:  
EXPERIENCE FROM AN ITALIAN OUTPATIENT CLINIC  
FOR MOVEMENT DISORDERS 
Susanne Buechner, Andrea La Licata, Dario Seppi, Francesco Teatini  
Department of Neurology/Stroke Unit, Bolzano Hospital, Bolzano/Bozen, Italy 
Abstract. Patients with chronic diseases such as Parkinson’s disease need periodic medical examinations. During the 
COVID-19 pandemic non-emergent medical visits were impossible. To ensure continuity of health care, telemedicine has 
been demonstrated to be a potential and useful tool. 
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Coronavirus disease 2019 (COVID-19), caused by the 
severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2), has rapidly become a world pandemic 
[1]. The fear of coronavirus contagion has led to self-
isolation and social distancing. In Italy, a hotspot of the 
pandemic, the COVID-19 infection spread within a few 
weeks from the initial foci (i.e. Codogno, a small town 
close to Milan, Lombardy) to the rest of the country [2]. 
In order to slow down the wave of infections, drastic 
governmental measures for containment of transmission 
were enacted. On March 8, 2020 a legal decree was 
issued, asking people of 16 North Italian provinces to 
stay indoors unless they need to buy food or medicine. 
These severe limitations to mobility were subsequently 
widened to the whole of Italy. Non-emergent surgical 
procedures and medical outpatient visits were also can-
celled. However, patients with chronic diseases, such as 
Parkinson’s disease (PD), need routine examinations for 
physical assessment and medication adjustments.   
In this setting of COVID-19, telemedicine (TM) has 
been promoted and used to triage or monitor COVID-19 
patients, reducing the risk of transmission, especially in 
the United Kingdom and the United States of America 
[3]. TM has already been suggested as a response to pub-
lic health emergencies [4]. The functional definition of 
TM is medicine delivered over distance, whereby the 
communication can be in real-time (i.e. synchronous) or 
not (i.e. asynchronous) [5]. TM has been around in some 
form for many centuries and some authors relate the first 
use of TM to be when ancient civilizations sent smoke 
signals to warn other clans of a contagious illness out-
break [6]. Of course, TM has changed during the centu-
ries, especially in the last decades due to significant and 
rapid improvement in the underlying enabling digital 
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technologies. There are many different types of TM, and 
phone calls or video conferencing replacing in-person 
outpatient visits are only one kind of TM [5]. TM has 
been already used successfully for many different fields, 
for example in asthma care over distance [7] or for dia-
betic retinopathy screening [8]; the validity of TM to as-
sess PD patients has been also well documented [9].  
Our Movement Disorders Outpatient Clinic is located 
in the Hospital of Bolzano, which belongs to the Auton-
omous Province of South Tyrol in Northern Italy. Our 
clinic provides, for more than 1000 patients, access to 
three neurologists specialized in diagnosing and treating 
movement disorders for assessment and follow-up. Our 
team includes three nurses, one of which is a PD nurse 
specialist. Our clinic also provides opportunities for pa-
tients to participate in research studies related to move-
ment disorders, characterized mainly by collaborative 
projects with other movement disorder outpatient clinics.  
In order to guarantee continuity of medical care for 
our established patients during the COVID-19 pandemic, 
our ambulatory in-person appointments were immedi-
ately converted to phone calls. All patients who had 
scheduled an in-person visit for March or April 2020 
were called by one of the three neurologists of our 
Movement Disorders Outpatient Clinic. In fact, no pre-
selection of patients’ suitability for TM had been per-
formed; in case of patients with cognitive impairment or 
reduced ability to use technology, we directly contacted 
their caregivers.  
We have made some interesting observations using 
TM. From March 10 until April 27, 2020 we called 150 
patients from our Movement Disorders Outpatient 
Clinic. No phone call was refused, and all patients 
wished for a telemedical contact rather than a face-to-
face consultation in order to avoid contact with poten-
tially infected persons. In total, 165 telephone-calls 
were made, as some patients had to be called two (11 
patients) or three times (2 patients). The mean age of the 
patients was 74 years (range: 45-96); 70 were females, 
80 were males. Most patients (115) had the diagnosis of 
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idiopathic PD or Parkinsonism, 18 patients suffered 
from essential tremor or other kinds of tremor, 14 pa-
tients had restless-legs syndrome, while the remaining 3 
patients were affected with rare movement disorders  (2 
patients with Huntington disease, 1 patient with stiff 
person syndrome) (Table 1). 
In nearly two thirds of the patients, clinical-therapeutic 
problems could be resolved during the telephone-call, and 
therefore the following out-patient visit could be scheduled 
for autumn. In 58 patients the phone call was not conclu-
sive, and therefore an in-person visit was necessary as soon 
as possible (Figure1). The mean age of these 58 patients 
was 72 years and most of them, namely 52 patients, suf-
fered from PD or Parkinsonism, 34 of which for more than 
5 years. In 24 patients from this group, the current therapy 
was modified during the telephone-call; 35 patients were 
on medication with two or more Anti-Parkinson drugs. 
Thus, these aspects (severe movement disorder disease, 
polymedication, advanced age) associated to other comor-
bidities (e.g. arterial hypertension or diabetes mellitus) 
influenced the need for an in-person encounter. 
In summary, despite one third of the 150 contacted 
patients of our Movement Disorders Outpatient Clinic 
needing an in-person visit, for the majority the phone 
calls were successful and could substitute the scheduled 
appointments. Of course, a phone-conversation is not the 
same as an in-person encounter and cannot replace an 
outpatient clinic, however, many of our patients seemed 
quite satisfied with the contact by telephone. This TM 
experience was also associated with satisfaction among 
our staff, permitting uninterrupted care of our patients, 
reducing the risk of SARS-CoV-2 transmission to other 
patients and ourselves and saving personal protective 
equipment. Finally, phone consultation worked without 
particular difficulties, and all patients were able to 
respond more or less immediately to the phone calls due 
to the lockdown introduced by the Italian government.  
Certainly, we have identified the need to improve our 
telehealth technology in the near future, using video-con-
ferencing instead of “simple” telephone-calls according 
to the practical guidance offered by the International Par-
kinson and Movement Disorder Society [10] and recom-
mended by other movement disorders specialists [11], as 
video consultations would give us also the possibility to 
see the patient and to assess clinical features. However, 
for this pandemic there was no time for adoption of video 
conferencing solutions, mainly due to technical issues, 
such as installing a dedicated video software or web cam-
eras on our and patients’ computers. Unfortunately, we 
were also unprepared for video consultations because Italy 
does not include TM in the essential levels of care granted 
to all citizens within the National Health Service [3].  
However, we should think about integration of TM 
within our health care system, guaranteeing, of course, a 
Table 1 Demographic and clinical characteristics of the contacted patients 
Total number 
and sex of pts. 
Mean age of pts. 
(years) 
Diagnosis with disease duration (>5 years)  
and PD polymedication ( 2 drugs) (number of pts.) 
150 74 (range 45-96) PD/Parkinsonism: 115; > 5 years: 76;  2 drugs: 67 
70 females 75 (range 45-96) ET/tremor: 18;  > 5 years: 11  
80 males 73 (range 45-93) RLS: 14;  > 5 years: 9 
  HD: 2;  > 5 years: 1 
  SPS: 1;  > 5 years: 1 
Abbreviations: pts.: patients; PD: Parkinson’s disease; ET: essential tremor;  
RLS: restless-legs syndrome; HD: Huntington disease; SPS: stiff person syndrome   
 
Fig. 1 Outcome of phone-calls during COVID-19 pandemic 
Abbreviations: SPS: stiff person syndrome, HD: Huntington disease,  
RLS: restless-legs syndrome, ET: essential tremor, PD: Parkinson’s disease 
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high-quality standard. Furthermore, after the current 
COVID-19 pandemic emergency TM might be consid-
ered a useful supplementary tool for our outpatient 
clinic, especially for established patients who are frag-
ile, who have significant difficulties of moving around 
and who need to be accompanied by a caregiver. In 
these cases, the utilization of TM would save travel-
costs and caregiver work-days, providing a positive 
effect also on the economy and on the environment. Of 
course, implementing TM takes time and does not hap-
pen overnight. TM is highly complex and full of chal-
lenges, and its integration requires precise guidelines. 
Adequate technical equipment, including modern de-
vices and a secure, high-speed Internet connection, is 
needed, which must be available for everybody, and 
easy to use also by elderly patients, unless relatives are 
on hand to help. Other challenges of TM include legal 
aspects, payment, credentialing, ethical considerations 
and staff training. In conclusion, although the presence 
of the COVID-19 pandemic is a dramatic event, it is 
also an opportunity for us to implement TM and to 
change something in long established processes and 
routines in our medical health care system. 
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